Teva Pharmaceutical Industries Ltd. (TEVA) Stock Quote

Detailed Quote for Teva Pharmaceutical Industries Ltd. (TEVA)

After Hours: $ 44.30

0.14 (+0.32%)

Volume: 12.98 k

4:13 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

February 17, 2011

Close: 52.35

52 Week Low

September 23, 2011

Close: 35.00

Today

Last Price
44.16

Change $
0.50

Change %
1.12%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
44.55

High
44.79

Low
43.78

Prev Close
44.66

Last Trade
2/10/12

Volume
4.97 m

52 Wk Hi
52.35

52 Wk Low
35.00

Market Cap
41.55 b

Ex-Div Date
11/10/11

Div Rate
0.70156

Yield
1.5887

Shares
941,000,000

EPS (TTM)
3.36

PE Ratio
13.10

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Teva Pharmaceutical Industries Ltd. (TEVA)

Sector News | Topic News

News for TEVA

Wed, Feb 08, 2012

12:30 AM

Teva UK Limited Launches Latanoprost + Timolol Eye Drops - PR Newswire

Thu, Feb 02, 2012

8:01 AM

Clinical Data on OGX-427 Presented at the ASCO 2012 Genitourinary Cancers Symposium Provide Ongoing Evidence of Hsp27 as a Potential Therapeutic Target in Advanced Prostate Cancer - Canada Newswire

8:01 AM

Phase 1 Study of OGX-427 Presented at the ASCO 2012 Genitourinary Cancers Symposium Shows Early Evidence of Activity in Bladder Cancer - Canada Newswire

8:00 AM

Phase 1 Study of OGX-427 Presented at the ASCO 2012 Genitourinary Cancers Symposium Shows Early Evidence of Activity in Bladder Cancer - PR Newswire

8:00 AM

Clinical Data on OGX-427 Presented at the ASCO 2012 Genitourinary Cancers Symposium Provide Ongoing Evidence of Hsp27 as a Potential Therapeutic Target in Advanced Prostate Cancer - PR Newswire

Thu, Jan 19, 2012

8:01 AM

OncoGenex Announces Presentation of OGX-427 Data at the ASCO 2012 Genitourinary Cancers Symposium - Canada Newswire

8:00 AM

OncoGenex Announces Presentation of OGX-427 Data at the ASCO 2012 Genitourinary Cancers Symposium - PR Newswire

Wed, Jan 18, 2012

1:00 AM

Teva UK Limited Launches Latanoprost Eye Drops - PR Newswire

Mon, Jan 16, 2012

11:47 PM

Teva to Report Fourth Quarter and Full Year 2011 Financial Results on February 15, 2012 - Business Wire

Mon, Jan 09, 2012

10:28 AM

Teva to Present at the 30th Annual J.P. Morgan Healthcare Conference - Business Wire

Wed, Jan 04, 2012

8:01 AM

OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology - Canada Newswire

8:00 AM

OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology - PR Newswire

6:40 AM

Teva to Restart Generic Animal Vaccine Production at Missouri Plant Following $14 Million FDA Compliance Investment, an Industrial Info News Alert - Marketwire

Tue, Jan 03, 2012

8:00 AM

Advanced Magnetic Resonance Imaging Technology Suggests Axonal Repair in Multiple Sclerosis Patients Treated with COPAXONE® - Business Wire

Sun, Jan 01, 2012

11:00 PM

Teva Announces Management Succession - Business Wire

Thu, Dec 22, 2011

7:30 AM

Dr. Rob Koremans to succeed Dr. Gerard van Odijk as President and CEO of Teva Europe - Business Wire

Wed, Dec 21, 2011

8:58 AM

Teva Provides 2012 Non-GAAP Financial Outlook; 2012 Non-GAAP Diluted EPS of $5.48 to $5.68 - Business Wire

7:30 AM

Teva Announces $3 billion Share Repurchase Program - Business Wire

Tue, Dec 13, 2011

4:54 PM

Teva to Host 2012 Business Outlook Conference Call - Business Wire

9:00 AM

Direction of Market Influences - Report Highlights Teva Pharmaceutical Industries Ltd (ADR) and Sanofi SA (ADR) - Marketwire

More News for TEVA >>

Tags for Teva Pharmaceutical Industries Ltd.

Research stocks or mutual funds related to Teva Pharmaceutical Industries Ltd. by keywords or tags. Find companies that have a similar focus to TEVA. The keywords below have been associated to TEVA by either user submission or electronic means.

top 10 pharmaceutical companies pharmaceuticals research pharmaceutical publication pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceutical investment medical product development pharmaceutical research and development pharmaceutical manufacturing company pharma marketing pharmaceutical companies usa pharma license list of pharmaceutical company kv pharmaceutical company American Depository Receipt (ADR) BETASERON pharmaceutical sales pharma pharmaceutical distributors top pharmaceutical company pharmaceutical development pharmaceutical sales rep pharmaceutical reports pharmaceutical magazine pharmaceutical consultant pharma product development pharmaceutical pr Drugs veterinary pharmaceuticals ranbaxy pharmaceuticals pharmaceutical auctions pharma r&d pharmaceutical manufacturing software pharmaceutical conference pharmaceutical manufacturing pharmaceutical formulation pharma reports company research largest pharmaceutical company generic pharmaceuticals contract pharmaceutical sun pharmaceutical industries ltd pharmaceutical consulting sun pharmaceutical industries research biotech pharmaceutical industry pharmacy companies pharmaceutical strategy pharmaceutical advances